A Phase 1 Study of Neratinib in Combination With Temsirolimus in Subjects With Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Neratinib (Primary) ; Temsirolimus
- Indications Advanced breast cancer; Colorectal cancer; Gynaecological cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours; Thymoma; Vulvovaginal cancer
- Focus Adverse reactions
- Sponsors Pfizer; Puma Biotechnology
- 09 Dec 2013 Results published in the Journal of Clinical Oncology.
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2012 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History